Explore the contrasting acceptance of gene therapy and genetic crop modification, highlighting societal attitudes and ...

Explore how gene drives in genetically modified mosquitoes could revolutionize malaria control and combat this deadly disease ...

Scientists are exploring genetically modified mosquitoes to reduce malaria transmission by altering mosquito populations at ...

Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing machinery into the right cells efficiently, safely, and at the scale needed for ...

With a few chemical tweaks and some dutiful protein partners, a new biotech from Flagship Pioneering thinks it has cracked ...

These days, it’s the most grown crop on the planet at 494 million acres a year, with nearly 20% of those in the U.S.  Farmers ...

Researchers at University of Toronto's Department of Chemical Engineering & Applied Chemistry have made a key discovery about ...

Eli Lilly is in talks to buy Kelonia Therapeutics for $2B+, boosting its oncology pipeline with next-gen CAR-T for multiple ...

It’s incredible how much our lives have changed over the last 50 years. If you were around back then, you’d remember a world ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

The heart, with its constant blood flow and dense network of blood vessels, might seem like a favorable environment for ...

Mesoblast Limited (NASDAQ:MESO) is one of the best low priced biotech stocks to invest in. Mesoblast Limited (NASDAQ:MESO) announced on April 14 that it has acquired an exclusive worldwide license to ...